| 000 | 01645 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516191846.0 | ||
| 264 | 0 | _c20140408 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1945-7197 | ||
| 024 | 7 |
_a10.1210/jc.2013-3264 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThankamony, A | |
| 245 | 0 | 0 |
_aShort-term administration of pegvisomant improves hepatic insulin sensitivity and reduces soleus muscle intramyocellular lipid content in young adults with type 1 diabetes. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _cFeb 2014 |
||
| 300 |
_a639-47 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHuman Growth Hormone _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xmetabolism |
| 650 | 0 | 4 |
_aLipid Metabolism _xdrug effects |
| 650 | 0 | 4 |
_aLiver _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
| 700 | 1 | _aTossavainen, P H | |
| 700 | 1 | _aSleigh, A | |
| 700 | 1 | _aAcerini, C | |
| 700 | 1 | _aElleri, D | |
| 700 | 1 | _aDalton, R N | |
| 700 | 1 | _aJackson, N C | |
| 700 | 1 | _aUmpleby, A M | |
| 700 | 1 | _aWilliams, R M | |
| 700 | 1 | _aDunger, D B | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 99 _gno. 2 _gp. 639-47 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jc.2013-3264 _zAvailable from publisher's website |
| 999 |
_c23447879 _d23447879 |
||